Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...
Հիմնական հեղինակներ: | Jihoon Lee, Min-Koo Choi, Im-Sook Song |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
MDPI AG
2023-05-01
|
Շարք: | Pharmaceuticals |
Խորագրեր: | |
Առցանց հասանելիություն: | https://www.mdpi.com/1424-8247/16/6/802 |
Նմանատիպ նյութեր
-
Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
: Edozie S. Okpara, և այլն
Հրապարակվել է: (2022-01-01) -
UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies
: Liyuan Ma, և այլն
Հրապարակվել է: (2024-02-01) -
Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)
: Jen-Ruei Chen, և այլն
Հրապարակվել է: (2008-09-01) -
Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
: Rui Chen, և այլն
Հրապարակվել է: (2023-08-01) -
Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
: Ranju Bansal, և այլն
Հրապարակվել է: (2021-04-01)